GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Cancers, MDPI AG, Vol. 13, No. 7 ( 2021-03-27), p. 1546-
    Abstract: Focused ultrasound (FUS) has shown promise as a non-invasive treatment modality for solid malignancies. FUS targeting to tumors has been shown to initiate pro-inflammatory immune responses within the tumor microenvironment. Pulsed FUS (pFUS) can alter the expression of cytokines, chemokines, trophic factors, cell adhesion molecules, and immune cell phenotypes within tissues. Here, we investigated the molecular and immune cell effects of pFUS on murine B16 melanoma and 4T1 breast cancer flank tumors. Temporal changes following sonication were evaluated by proteomics, RNA-seq, flow-cytometry, and histological analyses. Proteomic profiling revealed molecular changes occurring over 24 h post-pFUS that were consistent with a shift toward inflamed tumor microenvironment. Over 5 days post-pFUS, tumor growth rates were significantly decreased while flow cytometric analysis revealed differences in the temporal migration of immune cells. Transcriptomic analyses following sonication identified differences in gene expression patterns between the two tumor types. Histological analyses further demonstrated reduction of proliferation marker, Ki-67 in 4T1, but not in B16 tumors, and activated cleaved-caspase 3 for apoptosis remained elevated up to 3 days post-pFUS in both tumor types. This study revealed diverse biological mechanisms following pFUS treatment and supports its use as a possible adjuvant to ablative tumor treatment to elicit enhanced anti-tumor responses and slow tumor growth.
    Type of Medium: Online Resource
    ISSN: 2072-6694
    Language: English
    Publisher: MDPI AG
    Publication Date: 2021
    detail.hit.zdb_id: 2527080-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2020
    In:  Cancer Research Vol. 80, No. 16_Supplement ( 2020-08-15), p. 2665-2665
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 80, No. 16_Supplement ( 2020-08-15), p. 2665-2665
    Abstract: Major therapeutic advances in the field of tumor immunotherapy are hindered by the ability to overcome the immunosuppressive tumor microenvironment (TME), which prevents the immune system from mounting an efficient anti-tumor response. Pulsed focused ultrasound (pFUS) studies has shown some promise as an immunomodulatory strategy for altering TME. This study evaluated the temporal changes following non-ablative pFUS on TME immune cell profiles in spleen (Sp), lymph nodes (LN), and tumors (B16 melanoma and 4T1 mammary carcinoma). Murine B16 and 4T1 cells were subcutaneously, bilaterally implanted into C57BL/6J and BALB/c mice (n=10 tumors/time-point), respectively. Ultrasound guided pFUS (VIFU 2000, Alpinion) was administered at 1 MHz, at 6 MPa PNP to 5 mm tumors. Entire tumor volume was sonicated with a 2 mm spacing between points using a 10 ms pulse length, 10% duty cycle and a pulse repetition frequency of 10 Hz. At days 1, 3, and 5 post-sonication, Sp, LN and tumors were harvested, fixed and processed for flow cytometry (FACS) analysis of immune cell populations [cytotoxic (Tcyt), helper (Th), and regulatory (Treg) T cells, natural killer (NK), dendritic cells (DC), F4/80+ macrophages (M1 and M2), myeloid-derived suppressor cells (MDSC)] and immune checkpoint markers (CTLA-4, PD-1 and PD-L1). The immune response to pFUS differed between the B16 and 4T1 tumor bearing mice. B16 mice at days 1, 3 and 5 post-sonication revealed a 3-4 fold increase in Tcyt, Th, NK and M1 macrophage activity in tumor, which peaked at day 3, and decreased by day 5, compared to control tumors. At day 5, a shift of cell populations toward LN, with increased Treg, Tcyt, NK, F4/80, M1 and M2 activity was observed. 4T1 mice showed high levels of Tcyt in Sp on day 1, and NK cells on day 3 in LN. Interestingly, these cell populations decreased in Sp and LN by day 5, with 3-4 fold increase in 4T1 tumors, along with increasing macrophage and DC activity. Despite the differences in both tumor types, results suggest that pFUS altered the TME by inducing anti-tumor responses by activating both innate (macrophages, NK cells) and adaptive (Tcyt, Th cells) arms of immunity. This study reveals the differences in immune cell profiles following sonication between the two tumor types and underscores the importance of not generalizing the effect of pFUS on the TME. This analysis also suggests that the global changes to the immune cell profile represent a shift from anti-inflammatory, immunosuppressive TME towards an anti-tumor TME. Optimizing pFUS parameters to enhance immune cell infiltration, would presumably lead to slowing tumor growth rates and when coupled with immune checkpoint inhibits could serve as neoadjuvant approach in treating malignancy. Citation Format: Parwathy Chandran, Gadi Cohen, Scott R. Burks, Joseph A. Frank. Immune cell modulation of pulsed focused ultrasound in murine melanoma and breast cancer models [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2665.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2020
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Ultrasound in Medicine & Biology, Elsevier BV, Vol. 45, No. 12 ( 2019-12), p. 3232-3245
    Type of Medium: Online Resource
    ISSN: 0301-5629
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2019
    detail.hit.zdb_id: 1498918-9
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancers, MDPI AG, Vol. 12, No. 2 ( 2020-02-04), p. 350-
    Abstract: Image-guided focused ultrasound (FUS) has been successfully employed as an ablative treatment for solid malignancies by exposing immune cells to tumor debris/antigens, consequently inducing an immune response within the tumor microenvironment (TME). To date, immunomodulation effects of non-ablative pulsed-FUS (pFUS) on the TME are poorly understood. In this study, the temporal differences of cytokines, chemokines, and trophic factors (CCTFs) and immune cell populations induced by pFUS were interrogated in murine B16 melanoma or 4T1 breast cancer cells subcutaneously inoculated into C57BL/6 or BALB/c mice. Natural history growth characteristics during the course of 11 days showed a progressive increase in size for both tumors, and proteomic analysis revealed a shift toward an immunosuppressive TME. With respect to tumor natural growth, pFUS applied to tumors on days 1, 5, or 9 demonstrated a decrease in the growth rate 24 h post-sonication. Flow cytometry analysis of tumors, LNs, and Sp, as well as CCTF profiles, relative DNA damage, and adaptive T-cell localization within tumors, demonstrated dynamic innate and adaptive immune-modulation following pFUS in early time points of B16 tumors and in advanced 4T1 tumors. These results provide insight into the temporal dynamics in the treatment-associated TME, which could be used to evaluate an immunomodulatory approach in different tumor types.
    Type of Medium: Online Resource
    ISSN: 2072-6694
    Language: English
    Publisher: MDPI AG
    Publication Date: 2020
    detail.hit.zdb_id: 2527080-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Frontiers in Bioengineering and Biotechnology, Frontiers Media SA, Vol. 8 ( 2020-7-28)
    Type of Medium: Online Resource
    ISSN: 2296-4185
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2020
    detail.hit.zdb_id: 2719493-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 80, No. 16_Supplement ( 2020-08-15), p. 5606-5606
    Abstract: Focused ultrasound (FUS) ablation has been successfully used for thermal ablation of solid malignancies. However, non-ablative pulsed-FUS (pFUS) has received less attention but could be less destructive anti-tumor therapy by stimulating a pro-inflammatory immune response within the tumor microenvironment (TME). Clinically, such an approach could be useful to treat peripheral disease (e.g. micro-metastases) in otherwise normal-appearing tissues. Here, we explored the alterations of cytokines, chemokines and trophic factors (CCTF) and cell adhesion molecules (CAM) in the TME of mouse flank tumor models following pFUS treatment at different time points of tumor progression. Mice were bilaterally inoculated with subcutaneous B16 melanoma or 4T1 breast tumors into the hind limbs and allowed to reach diameters of ~5 mm (n=6/group/timepoint) before performing experiments (Day 1). Separate groups of mice were subjected to pFUS (1 MHz; Peak negative pressure = 6 MPa; Duty cycle = 10%, 100 pulses per site) at Days 1, 5, or 10 and euthanized 24 hr post-pFUS for proteomic analyses. Separate groups of time-matched tumor-bearing mice that did not receive pFUS were also euthanized at the same time points both to assess relative changes due to pFUS at each time point and provide information regarding the natural history of TME progression in each tumor type. Proteomic analyses in untreated control tumors revealed an overall shift toward immunosuppressive (pro-tumor) TME over the 10 days. When comparing proteomic effects of pFUS treatment in compared to untreated time-matched controls, tumors treated on Day 1 exhibited greater upregulation of pro-inflammatory (anti-tumor) CCTF and CAM and pFUS had less pronounced effects on the TME when administered in groups of mice treated at Days 5 or 10. To further examine the acute effects of pFUS at on CCTF and CAM over 72hr. pFUS treatment in elicited unique CCTF and CAM profiles for the two tumor types, but both could be considered shifted towards anti-tumoral TME, especially within the first 24 hrs. These data suggest that pFUS can potentially modulate TME in a therapeutically beneficial way. However, they reveal two important caveats that require substantial investigation: 1) Different tumor types have unique molecular responses and imply pFUS may be more suitable for certain tumor types; 2) Natural histories encompass dynamic TME changes as part of disease progression and appropriate timing of pFUS in each tumor type will be necessary to maximizing the potential therapeutic benefits of pFUS. Citation Format: Gadi Cohen, Parwathay Chandran, Lauren E. Tomlinson, Maggie E. Sundby, Rebecca M. Lorsung, Scott R. Burks, Joseph A. Frank. Characterization of temporal proteomic dynamics of murine breast and melanoma tumor microenvironments without and with pulsed focused ultrasound [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 5606.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2020
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2021
    In:  Cancer Research Vol. 81, No. 13_Supplement ( 2021-07-01), p. 2763-2763
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 81, No. 13_Supplement ( 2021-07-01), p. 2763-2763
    Abstract: Non-ablative image guided pulsed focused ultrasound (pFUS) has shown promise in murine tumor models as an immunomodulatory strategy for altering tumor microenvironment (TME). However, studies to date have demonstrated efficacy only in murine models procured from a single vendor. To determine whether differences in inbred mice obtained from 3 vendors would alter tumor growth and TME, we evaluated temporal expression of cytokine, chemokine and trophic factor (CCTF), and immune cell profiles following non-ablative pFUS to murine B16 melanoma flank tumors established in C57BL/6J mice. B16 cells (106 cells) were subcutaneously, bilaterally implanted into C57BL/6J mice (n=6/group/time-point) obtained from 3 vendors [Jackson Laboratories (JAX; n=36), Charles River (CR; n=36), Taconic Biosciences (Tac; n=36)]. Ultrasound guided pFUS (VIFU 2000, Alpinion) was administered at 1 MHz, at 6 MPa PNP to 5 mm tumors. Entire tumor volume was sonicated point-by-point along a 2×2 mm matrix with 20 msec pulse length, 10% duty cycle and a 5 Hz pulse repetition frequency. On days 1, 3, and 5 post-pFUS, spleens (Sp), lymph nodes (LN) and tumors were evaluated by proteomic (CCTF) and flow cytometry (FC) analyses. pFUS treatment demonstrated variable, vendor-dependent effects on tumor growth, CCTF and immune cell profiles. CR B16 volumes showed significant reduction (p & lt;0.05; 2-way ANOVA) starting at day 2 through day 5, but not in JAX or Tac mice. Proteomic analyses revealed a similar trend wherein CR TME exhibited upregulation of pro-inflammatory cytokines (TNFα, IL-1β, IL-12p70) on days 1 and 3, and downregulation of anti-inflammatory cytokines (VEGF, IL-10) over 5 days. Comparatively, less robust expression of anti-tumoral cytokines were observed in Tac and JAX TME over 5 days. FC corroborated tumor growth and molecular analyses, showing significant tumor infiltration of helper and cytotoxic T cells (Th, Tcyt), M1 macrophages and dendritic cells (DC) on days 3 and 5, compared to untreated controls. Day 5 CR Sp also exhibited a pro-inflammatory profile with T cells, macrophages and DC. Tac and JAX tumor profiles over days 1, 3 and 5 were relatively unchanged by pFUS with major, anti-tumoral immunological activity restricted to draining LN on days 5 and 3 in Tac and JAX, respectively. Moreover, molecular and immune cell differences were observed in B16 tumors from control mice on days 1, 3 and 5. Collectively, B16 bearing CR mice exhibited a more pronounced anti-tumor response to pFUS, resulting in reduced tumor growth and pro-inflammatory CCTF and immune cell profiles as compared to B16 tumors in Tac and JAX mice. Despite using the same mouse strain, tumor type, and pFUS parameters, profound vendor-dependent variability was observed, suggestive of the possible role of inherent genetic disparities among C57BL/6J mice from different vendors. These results suggest that vendor choice may be critical in evaluating anti-tumor effects of pFUS. Citation Format: Parwathy Chandran, Ruby Hutchison, Lauren Tomlinson, Gadi Cohen, Scott R. Burks, Joseph A. Frank. Effect of murine vendor on anti-tumor immune responses to non-ablative pulsed focused ultrasound [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2763.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2021
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2021
    In:  Cancer Research Vol. 81, No. 13_Supplement ( 2021-07-01), p. 2790-2790
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 81, No. 13_Supplement ( 2021-07-01), p. 2790-2790
    Abstract: Various cellular and biological immunotherapies have revolutionized the treatment of human malignancies by augmenting endogenous immune responses within the tumor microenvironment (TME). Although non-ablative pulsed-FUS (pFUS) has received less attention, it has been successfully used as a noninvasive treatment of solid malignancies by stimulating a pro-inflammatory immune response within the TME. Such an approach could be useful to treat peripheral micro-metastases in normal-appearing tissues. In the present study, we interrogated the immune-modulatory changes that occur within the TME following pFUS exposure. Murine B16 melanoma and 4T1 mammary carcinoma cells were subcutaneously implanted into both mice flanks (n=10 tumors/group/time point). The natural histories cytokine, chemokine, trophic factor (CCTF), and cell adhesion molecule (CAM) expression was evaluated within the TME of untreated flank tumors over 11 days. Ultrasound-guided pFUS at 1 MHz and peak negative pressures of 6 MPa was administered to tumors after reaching ~5 mm in diameter. Temporal immune-related changes in tumors were assessed following sonication using using proteomic, transcriptomic and histological analyses. Natural history growth characteristics showed a progressive increase in size for both tumors, and proteomic analysis revealed a shift toward an immunosuppressive TME. An anti-tumor TME was detected following pFUS treatment with increased expression of various pro-inflammatory CCTF and CAM as well as reduced tumor growth rates. Transcriptomic analyses following sonication identified inverted gene expression patterns in the two tumor types. Functional analysis of B16 tumors revealed increased intracellular signaling pathways associated with immune response regulations, while 4T1 tumors demonstrated reduced expression of proliferation genes. This study provides a macroscopic overview on the temporal dynamics of the TME and underline the profound magnitude of tumoral heterogeneity between tumor types as well as through progressive stages of similar primary tumors. Nevertheless, the induced immune-modulation changes suggest that pFUS may alter the expression of pro-inflammatory CCTF, CAM, towards an anti-tumoral TME, and supports the potential use of pFUS as a neoadjuvant treatment approach. Citation Format: Gadi Cohen, Parwathy Chandran, Rebecca M. Lorsung, Lauren E. Tomlinson, Robert B. Rosenblatt, Scott R. Burks, Joseph A. Frank. Temporal immune changes of murine breast and melanoma tumor microenvironments following pulsed focused ultrasound [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2790.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2021
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...